Ahngook takes over Biomedlap

Published: 2010-01-12 06:56:00

Updated: 2010-01-12 06:56:00

Ahngook Pharm said on January 8 it has acquired Biomedlab Co., a local bioventure company focusing on the development of artificial heart, DNA chips, and other biomedical products since its establishment in 1994.

Through its acquisition of Biomedlab, Ahngook will pave the way to produce and ma...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK